Summary: This paper deals with the study of CEA levels in urine from healthy control subjects, of patients with bladder carcinoma or previous bladder carcinoma, and other groups of patients. In 53% of the patients with bladder carcinoma and without urinary infection, urinary CEA was increased. There were no false positive results. It is concluded that urinary CEA is a valuable aid in the detection of malignant tumour growth in the bladder. The results are compared with several tumour parameters, e.g. tumour size, stage of disease and histological parameters.
Introduction
30 male patients. In a recent report (5) the same group extended their original work. The latter report indicated Carcino-embryonic antigen (CEA) was first described by yaluos < 35 ^ as normal fange for femaleS) which Gold&Freedman (1) . Studies on urinary carcinois quite diffefent from ^ range (< no ^/ ]} used in embryonic antigen levels were not undertaken until 1972. a previous study Guimn et d (6) repor ted that the In two interesting reports, Hall et al. (2, 3) presented mean C£A ]evd in urines of 24 patients with data indicating a possible correlation between increased bladder carcinoma was significantly higher than that amounts of urinary CEA and bladder carcinoma.
Q f nonna i subjects. CEA 1 ) levels in urine from healthy female subjects, however, showed widely varying and sometimes very
The above mentioned authors remarked that more data high levels. The same group extended their studies of are needed before the clinical value of CEA assays in male patients and reported elevated values (> 35 /*g/l) in urine can be definitely established. This study was 52 per cent of 45 patients (4) . This was a lower inci«Jarted in °r der *° extend available information on the dence than that in their original study (2) , covering clinical ^ ^ CEA measurements m the urine of 5 J ^ patients with bladder carcinoma. An attempt was .
made to correlate several parameters of the tumour *) Abbreviation: CEA = carcino-embryonic antigen.
with urinary CEA levels. In addition, some experiments were performed to gain more insight into the origin of the substance which is measured in the radioimmuno-assay for CEA in the urine of patients with bladder carcinoma.
Materials and Methods
Unless stated otherwise, urines were collected during cystocopy. Part of the samples of each urine was used to make cultures. The other pait of the samples was then dialysed for four hours against phosphate buffered saline (50 mmol/1 phosphate, 0.1 mmol/1 K 2 EDTA; pH 7.4), using cellulose acetate tubing. The dialysed portions were stored frozen until assay of CEA. Urinary cultures were grown on gel plates within a few hours of collection. In a number of cases the organisms were identified. Urinary infection was considered to be present if more than 10 8 colonies /I were found. CEA was measured in duplicate by the procedure described in a previous paper. Assays were performed in dialysed urines, undiluted and after dilution 1:2 with phosphate buffered saline (7) . Extracts were made of bacterial cultures of urine samples. Bacterial colonies were removed from the plates and powdered in a "microdismembrator" (Braun, Melsungen, Germany) at low temperature (cooling 'in liquid nitrogen). The complete procedure has been described elsewhere (8) . The powder was dissolved in the urine of healthy control subjects, containing less than "20 Mg/1 CEA. In the solution, thus prepared, CEA was measured. Vaginal and cervical discharges from women who were clinically free of carcinoma, were mixed with the urine of control subjects « 20 Mg/1 CEA) for two hours at room temperature. The mixture was centrifuged for 10 minutes at 3.000 r.p.m.
Control subjects
In order to establish normal CEA values, CEA was estimated in the urines of 78 healthy subjects, 41 male and 37 female. In these cases midstream instead of catheter urine was taken. The ages varied between 20 and 61 years (male) and between 18 and 59 years (female). Three of the male subjects used medication. Thirteen of the female subjects used oral contraceptives and three used other medication.
Patients
The patients could be divided in 4 groups: 3. 4 female patients with carcinomas of organs other than the bladder, i.e. 3 with cervical carcinoma and one with pyelum carcinoma. They had invasive tumour growth into the bladder as confirmed by cystoscopy but no infection of the urinary tract. 4. 19 patients who had an infection of the urinary tract but were not suffering from carcinoma, either at the time of urine collection or previously.
In all cases urinary CEA was estimated without knowledge of the clinical status of the subjects involved. Diagnosis was assessed and treatment given without reference to the CEA values. Therapeutic results were assessed and recorded independently of the results of the CEA assays.
Results

CEA levels in urine
Healthy controls
The results of CEA estimates in the urines of 41 males and 37 females are shown in figure 1 , column I and II.
Age, use of medication, length of menstrual cycle or time of urine collection in relation to the menstrual cycle had no demonstrable influence on the data. None of the subjects had a urinary infection. One woman, whose CEA level in midstream urine was 87 μg/l, allowed us to collect urine again, but with a catheter. Contrary to the midstream urine, the catheter urine contained less than 30 μ%1\ CEA. Figure 1 (column IV and V) shows the results of urinary CEA measurements in 53 patients without and 25 patients with urinary infection. Patients of both groups had evidence of bladder carcinoma. Of the 53 patients without urinary infection, 22 out of 41 men and 6 out of 12 women showed a urinary CEA excretion higher than 30 μg/l. There was no indication that parameters such as age», sex, time of diagnosis and previous treatment influenced the results.
Patients with bladder carcinoma
Patients with previous bladder carcinoma
Urinary CEA was measured in 113 patients without urinary infection and 21 patients with urinary infection. None of these patients showed evidence of bladder carcinoma at the time of the investigation. The data are presented in figure 1 (column VI). Of these subjects, 92 had a normal bladder wall at the time of the urine collection; 18 showed a bladder with one or more papillomes, i. e. non-invasive bladder carcinoma and 3 appeared to have a radiation ulcus. Figure 1 (column Ml) gives the results in 21 cases with a urinary infection.
Patients with primary carcinoma of other organs
Three patients (with cervical carcinoma) had CEA levels above 30 μg/l3 the patient with pyelum carcinoma had a CEA level below 30 //g/l. Figure 1 (column III) shows the CEA levels in the urines of 19 patients with urinary infection. These patients never had evidence of any carcinoma.
Patients with urinary infection only
Relatip.il of urinary CEA to several parameters
Size of the tumour
In 45 patients with bladder carcinoma but without urinary infection the results of CEA estimation in urine were considered in relation, to the diameter of the tumour, which was roughly measured at cystocopy. The diameter is supposed to be representative of the part of the tumour which is in contact with the bladder lumen, The data are listed in table 1. Stage of disease Table 2 lists several ranges of CEA levels according to the clinical stage (9) of disease in 52 patients.
Histology
In 34 patients, with bladder carcinoma but without urinary infection, histological findings were-compared with the result bf the nearest CEA estimation. The results are shown in table 3.
Additional experiments
We considered the possibility that elevated CEA levels in infected urine and in urine of female controls might be caused by interference in the CEA assay of excreted bacterial products and contamination of urine by vaginal or cervical secretion, respectively. Urinary extracts of homogenized bacteria, prepared as described under "Materials and Methods", were assayed for CEA. The bacteria studied were E. coli, Enterococcus and fig. 1 ) of values above 35 #g/l was found when measuring midstream samples. This range may constitute a problem in the interpretation of urinary CEA levels in female patients with bladder carcinoma. The data from figure 1 , column VI, demonstrate that the use of catheter urine solves this problem. Another conclusion which can be drawn from figure 1 (column I and VI) is that the upper limit of normal is 30 jigA-It should be noted that, if the standard inhibition curve permitted measurement in the 20-30 Mg/1 range (7), values between 20-30 μg/l were found in several cases in both groups. The borderline of 30 μg/l seems therefore real. Infection of the urinary tract leads to a rise of urinary CEA in even a larger percentage of cases than does bladder carcinoma (see fig. 1 , columns III and VII). In this respect it should be borne in mind that urinary infections can be associated with very high CEA levels. We therefore agree with Hall et al. (2) that the possibility of urinary infection has to be excluded before CEA levels are used for diagnostic purposes. We disagree with these authors that the problem of false positive values can be largely eliminated by the use of midstream urine. The possibility of false negatives in catheter urines must be accounted for ( fig. 1, column IV) .
Comparison with the data ofGuinan et al. (6) The only explanation for the increase in urinary CEA in infection seems to be that irritation or changing of the bladder mucus by the bacteria leads to release of CEA or substances with CEA-like activity. The fact that CEA activity in infected urines, urines with vaginal excretions and urines from bladders with a tumour show parallelism to the standard curve, leads to the conclusion that the active substances have antigenic groupings in common. We tried to absoro-out the antiserum with extracts of vaginal and cervical secretions in urine and found no residual activity against colonic CEA. A more precise description of the identity of the above substances cannot be given.
A relation between CEA levels and tumour diameters might be expected. Statistically, urinary CEA levels are indeed related to the tumour diameter (p = 0.035) (tab. 1) but not to the stage of disease (p = 0.36) (tab. 2) or to any of the histological parameters (p > 0.50 for any of the parameters) (tab. 3). Increased urinary CEA values are not only related to the bladder tumours, since invasive growth of other tumours into the bladder may also cause increased values.
Urinary CEA levels in patients with bladder carcinoma were elevated in 53% of the cases without infection ( fig. 1, column IV) . In none of 113 patients successfully treated for bladder carcinoma were increased CEA values ever obtained. In other words: there were no false positives results ( fig. 1 , column VI). Non infiltrating carcinomas of the bladder (so called papillomata) of such patients did not cause increased values. In view of these results, urinary CEA estimates are clinically valuable for detection of tumour growth in the bladder. To obtain diagnostically reliable CEA values in females a catheter specimen is indispensable. Since this is problematic in healthy females, urinary CEA estimates for screening purposes will be confined in practice to male subjects, ( fig. 1 , column I, IV and VI).
The follow-up findings will be presented in a subsequent publication.
